Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm, Experimental”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00513604
What this trial is testing

Phase II Study of Short-Term Cultured Anti-Tumor Autologous Lymphocytes After Lymphocyte-Depleting Chemotherapy in Metastatic Melanoma

Who this might be right for
MelanomaMalignant MelanomaMelanoma, Experimental+1 more
National Cancer Institute (NCI) 158
Not applicableStudy completedNCT07460570
What this trial is testing

Nurse-Led Culturally Adapted Palliative and End-of-Life Training for Oncology Nurses in Oman

Who this might be right for
Neoplasms (Cancer / Tumors)Palliative CareTerminal Care
Sultan Qaboos University 189
Not applicableStudy completedNCT01105169
What this trial is testing

Precision-Based Magnesium Trial

Who this might be right for
Colorectal Cancer
Vanderbilt University Medical Center 250
Large-scale testing (Phase 3)WithdrawnNCT03417037
What this trial is testing

An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerNon-Small Cell Lung Cancer
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT02723006
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Participants With Advanced Melanoma

Who this might be right for
Melanoma
Millennium Pharmaceuticals, Inc. 22
Not applicableUnknownNCT01980134
What this trial is testing

The MORDIS Study Clinical Investigational Plan

Who this might be right for
Adenoma
SpectraScience 1,200
Early research (Phase 1)Study completedNCT04382352
What this trial is testing

B002 in Patients With HER2-positive Breast Cancer

Who this might be right for
Recurrent Breast CancerMetastatic Breast Cancer
Shanghai Pharmaceuticals Holding Co., Ltd 23
Testing effectiveness (Phase 2)Study completedNCT01101334
What this trial is testing

Study of Erlotinib With or Without Investigational Drug (CS-7017) in Subjects With Advanced Non-small Cell Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung Cancer (NSCLC)
Daiichi Sankyo 90
Testing effectiveness (Phase 2)Looking for participantsNCT06780098
What this trial is testing

Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01I/KEYMAKER-U01I)

Who this might be right for
Lung Neoplasm
Merck Sharp & Dohme LLC 144
Very early researchLooking for participantsNCT07132645
What this trial is testing

An Investigational Scan ([68Ga] Ga-FAPI-04 PET/CT) for the Imaging of Patients With High-Grade Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Tumor
University of Michigan Rogel Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00429416
What this trial is testing

Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

Who this might be right for
Hematologic Malignancies
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14
Testing effectiveness (Phase 2)Looking for participantsNCT05848765
What this trial is testing

Relapsed Follicular Lymphoma Randomised Trial Against Standard ChemoTherapy

Who this might be right for
Relapsed Follicular LymphomaRefractory Follicular Lymphoma
University of Birmingham 284
Early research (Phase 1)Study completedNCT03661632
What this trial is testing

An Investigational Immunotherapy Study of BMS-986310 Administered Alone and in Combination With Nivolumab in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Cancer
Bristol-Myers Squibb 27
Not applicableNo Longer AvailableNCT04452994
What this trial is testing

Individual Patient Investigational New Drug (IND) Expanded Access Program of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy for Participant With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Study completedNCT05496231
What this trial is testing

A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Age

Who this might be right for
Cervical Intraepithelial Neoplasia
GlaxoSmithKline 1,080
Testing effectiveness (Phase 2)Study completedNCT00932451
What this trial is testing

An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Pfizer 1,069
Not applicableEnded earlyNCT05645744
What this trial is testing

Long-term Follow-up Study in Patients Previously Treated With a Mustang Bio CAR-T Cell Investigational Product.

Who this might be right for
Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)Chronic Lymphocytic Leukemia in RelapseSmall Lymphocytic Lymphoma, Relapsed+8 more
Mustang Bio 3
Early research (Phase 1)Study completedNCT04299048
What this trial is testing

Study to Assess the Safety and Tolerability of Repeated Doses of an Investigational New Drug in Patients With Cancer and Cachexia.

Who this might be right for
CachexiaNon-Small-Cell Lung CancerPancreatic Cancer+1 more
Pfizer 11
Large-scale testing (Phase 3)Study completedNCT03031938
What this trial is testing

Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies

Who this might be right for
OsteoarthritisCancer PainRecurrent Low Back Pain
Pfizer 4
Testing effectiveness (Phase 2)Study completedNCT00795899
What this trial is testing

Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO)

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 230
Next Page